Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +7.53% | +18.62% | +135.29% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +7.53% | ||
1 week | +18.62% | ||
Current month | +14.61% | ||
1 month | +22.32% | ||
3 months | +139.52% | ||
6 months | +124.72% | ||
Current year | +135.29% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4 | +7.53% | 175,147 |
24-05-15 | 3.72 | +12.05% | 198,150 |
24-05-14 | 3.32 | -2.35% | 68,633 |
24-05-13 | 3.4 | -2.02% | 55,629 |
24-05-10 | 3.47 | +2.91% | 185,356 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+135.29% | 58.03M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ABIO Stock